Desmopressin testing in von Willebrand disease: Lowering the burden

Autor: Heijdra, Jessica M., Atiq, Ferdows, Al Arashi, Wala, Kieboom, Quincy, Wuijster, Esmee, Meijer, Karina, Kruip, Marieke J.H.A., Leebeek, Frank W.G., Cnossen, Marjon H. ^*, Fijnvandraat, K., Mathôt, R.A.A., Polinder, S., Coppens, M., Tamminga, R.Y.J., Meijer, K., Laros‐van Gorkom, B.A.P., Brons, P., Schols, S.E.M., van der Meer, F.J.M., Eikenboom, H.C.J., Schutgens, R.E.G., Fischer, K., Heubel‐Moenen, F., Nieuwenhuizen, L., Ypma, P., Driessens, M.H.E., Zwaan, C.M., van Vliet, I., Collins, P.W., Liesner, R., Chowdary, P., Keeling, D., Lock, J., Hazendonk, H.C.A.M., van Moort, I., Preijers, T., de Jager, N.C.B., Goedhart, M.C.H.J., Bukkems, L.H., Cloesmeijer, M.E., Janssen, A.

Publikováno v: In Research and Practice in Thrombosis and Haemostasis August 2022 6(6)

Innovating the treatment of inherited bleeding disorders by pharmacokinetic- and pharmacodynamic-guided dosing

Autor: Bukkems, L.H.

Hemophilia A, hemophilia B and von Willebrand disease (VWD) are inherited bleeding disorders that are mostly treated with factor concentrates to prevent bleeding. When persons receive the same factor concentrate dose per kilogram bodyweight, large di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::eb0159dd375df63345dd6065ea051af1
https://dare.uva.nl/personal/pure/en/publications/innovating-the-treatment-of-inherited-bleeding-disorders-by-pharmacokinetic-and-pharmacodynamicguided-dosing(743a5645-0260-4d16-a8e5-052f9d754a76).html

One piece of the puzzle

Autor: Jager, N.C.B. de, Bukkems, L.H., Heijdra, J.M., Hazendonk, C.H.C.A.M., Fijnvandraat, K., Meijer, K., Eikenboom, J., Laros-van Gorkom, B.A.P., Leebeek, F.W.G., Cnossen, M.H., Mathot, R.A.A., Kruip, M.J.H.A., Polinder, S., Lock, J., Hazendonk, H.C.A.M., Moort, I. van, Goedhart, M.C.H.J., Coppens, M., Peters, M., Preijers, T., Tamminga, R.Y.J., Brons, P., Meer, F.J.M. van der, Eikenboom, H.C.J., Schutgens, R.E.G., Fischer, K., Driessens, M.H.E., Zwaan, C.M., Vliet, I. van, Collins, P.W., Liesner, R., Chowdary, P., Keeling, D., OPTI-CLOT Grp

Publikováno v: Journal of Thrombosis and Haemostasis, 18(2), 295-305. Wiley
Journal of thrombosis and haemostasis, 18(2), 295-305. Wiley-Blackwell
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, 18, 295-305
Journal of Thrombosis and Haemostasis, 18, 2, pp. 295-305
Journal of Thrombosis and Haemostasis, 18(2), 295-305. WILEY
Journal of Thrombosis and Haemostasis, 18, 295-305. Wiley-Blackwell Publishing Ltd

Contains fulltext : 218302.pdf (Publisher’s version ) (Open Access) INTRODUCTION: Many patients with von Willebrand disease (VWD) are treated on demand with von Willebrand factor and factor VIII (FVIII) containing concentrates present with VWF and/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1738ec01008e7a7165c9dd92023c2a70
https://doi.org/10.1111/jth.14652

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.